A PHASE IB/IIA, RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED, MULTIPLE-ASCENDING DOSE, PARALLEL-GROUP STUDY TO INVESTIGATE THE SAFTEY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF RO7126209 FOLLOWING INTRAVENOUS INFUSION IN PATIENTS WITH PRODROMAL OR MILD TO MODERATE ALZHEIMER'S DISEASE

  • Darby, David (Primary Chief Investigator (PCI))
  • Kerris, Jarrod (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date29/07/2131/12/24

Keywords

  • Alzheimer's disease
  • Neurogenerative disorder
  • Clinical trial